Survival benefit of adding Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at the different time-points of treatment of ovarian cancer: review of evidence.
about
Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy-current perspectivesNanovehicles as a novel target strategy for hyperthermic intraperitoneal chemotherapy: a multidisciplinary study of peritoneal carcinomatosisThe feasibility of administering varying high-dose consolidation hyperthermic intraperitoneal chemotherapy with carboplatin in the treatment of ovarian carcinoma.Consolidation hyperthermic intraperitoneal chemotherapy and maintenance chemotherapy following laparoscopic cytoreductive surgery in the treatment of ovarian carcinoma.Platelet Dynamics in Peritoneal Carcinomatosis Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal OxaliplatinManagement of recurrent epithelial ovarian cancer.Safety considerations for Health care Workers involved in Cytoreductive Surgery and Perioperative chemotherapy.The role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer: A Review.Cytoreduction (Peritonectomy Procedures) Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Advanced Ovarian Cancer: Retrospective Italian Multicenter Observational Study of 511 Cases.Melphalan: a promising agent in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent ovarian carcinoma: analysis of 30-day morbidity and mortality.Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all.Hyperthermic intraperitoneal chemoperfusion as a component of multimodality therapy for ovarian and primary peritoneal cancer.The Initial Indian Experience with Cytoreductive Surgery and HIPEC in the Treatment of Peritoneal Metastases.201 consecutive cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) procedures in a single Asian tertiary centre.Surgical Treatment of Colorectal Cancer with Peritoneal and Liver Metastases Using Combined Liver and Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Report from a Single-Centre Experience.Rate and extent of oxaliplatin absorption after hyperthermic intraperitoneal administration in peritoneal carcinomatosis patients.The role of heated intraperitoneal chemotherapy (HIPEC) in ovarian cancer: hope or hoax?Patients with Peritoneal Carcinomatosis from Gastric Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is Cure a Possibility?Both heat and new chemotherapeutic drug dioxadet in hyperthermic intraperitoneal chemoperfusion improved survival in rat ovarian cancer model.Magnetic nanoparticle hyperthermia potentiates paclitaxel activity in sensitive and resistant breast cancer cellsSurvival Benefit of Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer: A Multi-institutional Case Control Study
P2860
Q26744031-0A1ABCFF-25A3-403B-92FD-3A081E92D000Q28395895-5D191173-811B-4BDC-A589-70DD2593DB93Q33419382-9D386C81-703E-4252-9ED1-DD6BCF6B1CCDQ33419612-31C582BD-615E-41C5-9578-A167CAF575C4Q33427607-CA0E15EB-F14F-4386-9270-5C4A421E26C3Q34070046-BEF74D06-CF0C-4B4C-80C8-2CFA1FEA9896Q36758912-34AB57BD-266A-436F-8E35-48DBF19055D3Q36758929-255A29DE-F513-4514-A5DB-237F3A670DAFQ37683243-889C8889-433D-42A3-8B08-DD5E2472ADCCQ38166245-66BE1B03-C5BA-4E66-9047-D1A2C54CEC64Q38243089-4E015E80-FDE9-4539-8C07-CA4899FFD288Q38561332-728F5C88-C4C6-4B37-91E6-4725A6F96D53Q38719149-CCB4E1AC-2B0A-4B71-B156-A46432E17E45Q38882994-948182D2-7902-4686-B03B-EFEE0C288D9AQ39010898-96B497EA-8D79-46D6-B8D3-EA19AD381130Q39373406-41887443-ED38-425C-BF0F-A3E2CC0024A1Q42650614-C9546B16-5D88-43D5-AD76-BB98082B29B6Q47566178-08943EBE-C4E4-4AE8-B9CB-42B08DCDD251Q53213677-3B7B1292-79A5-4FAD-A765-4DABB9D78EFAQ53233948-0667C8C1-3C06-4B9C-80B6-1DA6649613E0Q57167802-DABB1B00-D734-4383-BB11-A8F012270EFEQ58051872-D9A15FE0-F640-4454-B039-6EEE21B87153
P2860
Survival benefit of adding Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at the different time-points of treatment of ovarian cancer: review of evidence.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Survival benefit of adding Hyp ...... an cancer: review of evidence.
@en
type
label
Survival benefit of adding Hyp ...... an cancer: review of evidence.
@en
prefLabel
Survival benefit of adding Hyp ...... an cancer: review of evidence.
@en
P2093
P1476
Survival benefit of adding Hyp ...... an cancer: review of evidence.
@en
P2093
Claude Finet
Denis Vanderbeeken
Fabienne Bastin
Jean-Olivier Amiel
Jean-Philippe Pahaut
Jean-Pierre Claes
Luc Marcelis
Sophie Cran
Stefaan Mulier
Thierry Velu
P304
P356
10.2174/138161212802002616
P577
2012-01-01T00:00:00Z